A spectroscopic liquid biopsy with artificial intelligence for the early detection of cancer and other diseases.

A REVOLUTIONARY SPECTROSCOPIC LIQUID BIOPSY

Based on patented platform technology, the ClinSpec Dx™ spectroscopic liquid biopsy is a simple blood test able to discover disease early. 

This low-cost technology has the potential to revolutionise the patient pathway; improving survival and quality-of-life to millions of patients worldwide.

And it's as simple and Drop, Dry, Detect™.

SHINING A LIGHT ON BRAIN TUMOURS

Brain tumours are difficult to detect, meaning that patients often recieve their diagnoses far too late. This patient pathway would greatly benefit from a liquid biopsy test that could help detect these patients earlier. 

 

ClinSpec Dx™ aims to change the statistics that surround brain tumours.

Newsroom

Read more here and follow us on social media platforms

  • White Twitter Icon
  • White LinkedIn Icon

Contact Us

Please contact us here or via email below

LATEST NEWS

MAR 2020

ClinSpec Dx highlighted

out by the PM

FEB 2020

Best British Tech Pioner 

2020 

JAN 2020

USA and EU patent

granted for cancer 

New Logo.png

Technology & Innovation Centre

99 George St, G1 1RD

Glasgow, Scotland

Privacy Policy

  • Visit ClinSpec Dx on Twitter
  • Visit ClinSpec Dx on LinkedIn